4.7 Article

Fas-positive T cells regulate the resolution of airway inflammation in a murine model of asthma

Journal

JOURNAL OF EXPERIMENTAL MEDICINE
Volume 203, Issue 5, Pages 1173-1184

Publisher

ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20051680

Keywords

-

Funding

  1. NCI NIH HHS [P30 CA014599, P30-CA14599] Funding Source: Medline
  2. NHLBI NIH HHS [T32 HL007605, R01 HL066026, T32 HL-07605, R01 HL66026] Funding Source: Medline
  3. NIAID NIH HHS [P01 AI56352, R01 AI46549, R01 AI046549, R01 AI050180, P01 AI056352, R01 AI50180] Funding Source: Medline

Ask authors/readers for more resources

Persistent airway inflammation, mucus production, and airway hyperreactivity are the major contributors to the frequency and severity of asthma. Why lung inflammation persists in asthmatics remains unclear. It has been proposed that Fas-mediated apoptosis of inflammatory cells is a fundamental mechanism involved in the resolution of eosinophilic airway inflammation. Because infiltrating eosinophils are highly sensitive to Fas-mediated apoptosis, it has been presumed that direct ligation of Fas on eosinophils is involved. Here, we utilize adoptive transfers of T cells to demonstrate that the delayed resolution of eosinophilia in Fas-deficient mice is a downstream effect of Fas deficiency on T cells, not eosinophils. Interestingly, the mice that received Fas-deficient T cells, but not the controls, developed a persistent phase of inflammation that failed to resolve even 6 wk after the last challenge. This persistent phase correlated with decreased interferon (IFN)gamma production by Fas-deficient T cells and could be reproduced with adoptive transfer of IFN gamma-deficient T cells. These data demonstrate that Fas deficiency on T cells is sufficient for the development of long-term allergic airway disease in mice and implies that deregulation of death receptors such as Fas on human T cells could be an important factor in the development and/or chronic nature of asthma.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available